Publikationen in Zusammenarbeit mit Forschern von Centro de Investigación Cooperativa en Biotecnología (10)

2024

  1. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

    JHEP Reports, Vol. 6, Núm. 1

  2. SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer

    Cell Reports, Vol. 43, Núm. 3

2022

  1. Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals

    Hepatology, Vol. 75, Núm. 3, pp. 550-566

  2. Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH

    Journal of Hepatology, Vol. 75, Núm. 1, pp. 34-45

2020

  1. Liver osteopontin is required to prevent the progression of age-related nonalcoholic fatty liver disease

    Aging Cell, Vol. 19, Núm. 8

2019

  1. SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer

    EBioMedicine, Vol. 40, pp. 406-421

2012

  1. A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis

    Genes and Immunity, Vol. 13, Núm. 1, pp. 21-28

2007

  1. ITGA4 polymorphisms and susceptibility to multiple sclerosis

    Journal of Neuroimmunology, Vol. 189, Núm. 1-2, pp. 151-157

2006

  1. Celecoxib inhibits interleukin-12 αβ and β2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum

    Molecular Pharmacology, Vol. 69, Núm. 5, pp. 1579-1587